|
A string of scandals have been
revealed in the drug industry recently, ranging from covered-up drug
risks to falsified data.
In yet another incident, research results were submitted under
the name of a doctor who had neither written it, reviewed it, nor
verified its accuracy.
40 Percent
Removed
Procter and Gamble may have removed as much as 40 percent of the
data from a recent study of the osteoporosis drug Actonel, according
to Dr. Aubrey Blunsohn (a British researcher and bone expert),
distorting the final results.
Then, not only did Procter and Gamble submit results under his
name, they wouldn't allow him to look at the final version until
months after it was submitted to the American Society for
Bone and Mineral Research.
Trying to Ensure
Accuracy
Scientific journals are still grappling with how to ensure that
results they print are complete and accurate in light of these
problems. It's a difficult question, especially since drug companies
fund roughly 70 percent of studies of medications in the
United
States. The results they get are
increasingly being shown to be biased and inaccurate.
After the bad publicity following attempted cover-ups of the
increased suicide risk connected with antidepressants and heart
problems associated with Vioxx, the drug companies vowed to do
better. Medical journals and some politicians are trying to take
steps to ensure that they do.
Should Companies Help Write
the Studies They Fund ?
But problems remain. While many leading scientific journals
require researchers to affirm that they analyzed all the raw data,
not averages or compilations from someone else, a recent survey
found a 17 percent rate of reported disputes over access to data.
There was also widespread disagreement over whether companies
that pay for research should help write results for publication.
|